GLOW Blend (GHK-Cu + BPC-157 + TB-500)
The GLOW Blend combines three potent regenerative peptides: GHK-Cu for skin elasticity and tissue remodeling, BPC-157 for accelerated healing of tendons and gut mucosa, and TB-500 for cellular migration and systemic recovery. Research suggests this combination synergistically promotes comprehensive tissue repair, anti-aging benefits, and reduced inflammation.
01Dosing reference
02Mechanism of action
Copper Delivery and Actin Upregulation
GHK-Cu delivers copper to cells to stimulate collagen production, while TB-500 upregulates actin, a vital cellular building block.
Angiogenesis and Fibroblast Activation
BPC-157 promotes the formation of new blood vessels (angiogenesis) and all three peptides stimulate fibroblast activity for tissue regeneration.
Systemic Healing and Anti-Aging
The combined mechanisms lead to accelerated wound healing, improved skin elasticity, and systemic reduction in inflammation.
03Human evidence
GHK-Cu has demonstrated efficacy in human clinical trials for improving skin elasticity, reducing wrinkles, and promoting hair growth when applied topically or injected.
Various dermatological studies on aging populations.
BPC-157 and TB-500 lack large-scale human clinical trials for systemic injection, though BPC-157 has early human data for inflammatory bowel disease.
Limited human trials; mostly anecdotal or early-phase data for systemic use.
04Preclinical evidence
BPC-157 significantly accelerates the healing of transected rat Achilles tendons and promotes gut lining repair.
Rodent models of tendon injury and gastric ulcers.
TB-500 (Thymosin Beta-4) enhances wound healing and reduces inflammation in various animal models of tissue injury.
In vivo studies on cardiac and skeletal muscle repair.
05What is known vs. unknown
- GHK-Cu is well-documented for its ability to stimulate collagen and elastin production.
- BPC-157 promotes angiogenesis and protects the gastrointestinal endothelium.
- TB-500 facilitates cellular migration and tissue repair through actin binding.
- The combination targets both aesthetic (skin/hair) and structural (muscle/tendon) recovery.
- The synergistic effects of combining all three peptides simultaneously have not been rigorously studied in controlled clinical trials.
- Long-term safety of systemic GHK-Cu injections remains under-researched compared to topical applications.
- Optimal dosing ratios for the blend are based on anecdotal protocols rather than standardized clinical guidelines.